ADAP Advocacy released a new infographic on October 15, 2026, as part of its ongoing 340B Project, drawing attention to the troubling disconnect between the 340B Drug Pricing Program's expansion and its original mission. The infographic reinforces the central message of a policy paper and commercial released earlier this year under the same name: "340B PROGRAM: The Glue That Should Hold Our Healthcare System Together." The timing of this release is critical, as it arrives amid intensifying national debate over the program's unchecked growth and its real-world impact on patient care.
Congress created the 340B Drug Pricing Program to extend federal resources and improve patient care, with the Affordable Care Act adding requirements for hospitals to provide free care and financial aid to poor patients, known as charity care. However, charity care continues to decline year after year even as 340B drug purchases soared above $100 billion in 2025 across over 42,000 covered entities and over 32,000 pharmacies. This explosive growth, without corresponding increases in charity care, suggests that the program may be failing to deliver on its promise. The infographic connects these dots, showing how the program's unfettered expansion is not translating into better outcomes for the vulnerable populations it was designed to serve.
The infographic continues ADAP Advocacy's '340B Too Big To Fail' national advocacy campaign, highlighting hospitals' declining charity, rising healthcare executive compensation, and exploding patient medical debt, among other issues. These trends raise serious questions about whether the 340B program is being used as intended or has become a financial boon for hospitals and executives at the expense of patients. The campaign's name itself, 'Too Big To Fail,' underscores the program's entrenched position and the challenges of reforming it, even as evidence mounts of its shortcomings.
The implications of this infographic are significant. It adds to a growing body of evidence that the 340B program requires greater oversight and reform to ensure it fulfills its original purpose. As healthcare costs continue to rise and patient medical debt reaches crisis levels, the need for accountability in the 340B program has never been more urgent. The infographic can be downloaded online here: https://tinyurl.com/y6asjaw2. By making this information accessible, ADAP Advocacy aims to inform policymakers, healthcare stakeholders, and the public about the program's real impact.
ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. The organization works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration. This latest infographic is a tool in that effort, providing visual evidence of the 340B program's misalignment with its goals and sparking conversations about necessary reforms.
